Latest News

Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

June 26, 2026, Everest Medicines today announced that China’s National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL(R) (lerodalcibep), a third-generation...

GMG Applies for Additional Environmental Approvals to Produce Graphene in USA

Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that the Company has submitted an additional application...

Popular:

Tong Ren Tang Healthcare (02667.HK) Targets Hong Kong IPO

On June 26, 2026, Beijing Tong Ren Tang Healthcare...

IP Go-Global Business Matching Session held in Guangzhou

- Some 50 business matching sessions support Chinese Mainland...

Business

Events

Marketing

Technology

Medical